Prevalence, Management, and Outcome of Atrial Fibrillation and Other Supraventricular Arrhythmias in COVID-19 Patients

Michele Magnocavallo; Giampaolo Vetta; Domenico G Della Rocca; Carola Gianni; Sanghamitra Mohanty; Mohamed Bassiouny; Luca Di Lullo; Armando Del Prete; Donatello Cirone; Carlo Lavalle; Cristina Chimenti; Amin Al-Ahmad; J David Burkhardt; G Joseph Gallinghouse; Javier E Sanchez; Rodney P Horton; Luigi Di Biase; Andrea Natale

doi:10.1016/j.ccep.2021.10.001

Prevalence, Management, and Outcome of Atrial Fibrillation and Other Supraventricular Arrhythmias in COVID-19 Patients

Michele Magnocavallo, Giampaolo Vetta, Domenico G Della Rocca, Carola Gianni, Sanghamitra Mohanty, Mohamed Bassiouny, Luca Di Lullo, Armando Del Prete, Donatello Cirone, Carlo Lavalle, Cristina Chimenti, Amin Al-Ahmad, J David Burkhardt, G Joseph Gallinghouse, Javier E Sanchez, Rodney P Horton, Luigi Di Biase, Andrea Natale

Research output: Contribution to journal › Article › peer-review

7 Citations (Scopus)

Abstract

COVID-19 mainly affects the respiratory system but has been correlated with cardiovascular manifestations such as myocarditis, heart failure, acute coronary syndromes, and arrhythmias. Cardiac arrhythmias are the second most frequent complication affecting about 30% of patients. Several mechanisms may lead to an increased risk of cardiac arrhythmias during COVID-19 infection, ranging from direct myocardial damage to extracardiac involvement. The aim of this review is to describe the role of COVID-19 in the pathogenesis of cardiac arrhythmias and provide a comprehensive guidance for their monitoring and management.

Original language	English
Pages (from-to)	1-9
Number of pages	9
Journal	Cardiac electrophysiology clinics
Volume	14
Issue number	1
DOIs	https://doi.org/10.1016/j.ccep.2021.10.001
Publication status	Published - Mar 2022
Externally published	Yes

Bibliographical note

Keywords

Atrial Fibrillation/surgery
Atrial Flutter
COVID-19/complications
Catheter Ablation/adverse effects
Humans
Prevalence
SARS-CoV-2
Tachycardia, Supraventricular

Access to Document

10.1016/j.ccep.2021.10.001

Handle.net

Persistent link

Cite this

Magnocavallo, M., Vetta, G., Della Rocca, D. G., Gianni, C., Mohanty, S., Bassiouny, M., Di Lullo, L., Del Prete, A., Cirone, D., Lavalle, C., Chimenti, C., Al-Ahmad, A., Burkhardt, J. D., Gallinghouse, G. J., Sanchez, J. E., Horton, R. P., Di Biase, L., & Natale, A. (2022). Prevalence, Management, and Outcome of Atrial Fibrillation and Other Supraventricular Arrhythmias in COVID-19 Patients. Cardiac electrophysiology clinics, 14(1), 1-9. https://doi.org/10.1016/j.ccep.2021.10.001

@article{607ee25dc9544cda81a3cf6089c88b6f,

title = "Prevalence, Management, and Outcome of Atrial Fibrillation and Other Supraventricular Arrhythmias in COVID-19 Patients",

abstract = "COVID-19 mainly affects the respiratory system but has been correlated with cardiovascular manifestations such as myocarditis, heart failure, acute coronary syndromes, and arrhythmias. Cardiac arrhythmias are the second most frequent complication affecting about 30% of patients. Several mechanisms may lead to an increased risk of cardiac arrhythmias during COVID-19 infection, ranging from direct myocardial damage to extracardiac involvement. The aim of this review is to describe the role of COVID-19 in the pathogenesis of cardiac arrhythmias and provide a comprehensive guidance for their monitoring and management.",

keywords = "Atrial Fibrillation/surgery, Atrial Flutter, COVID-19/complications, Catheter Ablation/adverse effects, Humans, Prevalence, SARS-CoV-2, Tachycardia, Supraventricular",

author = "Michele Magnocavallo and Giampaolo Vetta and {Della Rocca}, {Domenico G} and Carola Gianni and Sanghamitra Mohanty and Mohamed Bassiouny and {Di Lullo}, Luca and {Del Prete}, Armando and Donatello Cirone and Carlo Lavalle and Cristina Chimenti and Amin Al-Ahmad and Burkhardt, {J David} and Gallinghouse, {G Joseph} and Sanchez, {Javier E} and Horton, {Rodney P} and {Di Biase}, Luigi and Andrea Natale",

year = "2022",

month = mar,

doi = "10.1016/j.ccep.2021.10.001",

language = "English",

volume = "14",

pages = "1--9",

journal = "Cardiac electrophysiology clinics",

issn = "1877-9182",

publisher = "Elsevier",

number = "1",

}

Magnocavallo, M, Vetta, G , Della Rocca, DG, Gianni, C, Mohanty, S, Bassiouny, M, Di Lullo, L, Del Prete, A, Cirone, D, Lavalle, C, Chimenti, C, Al-Ahmad, A, Burkhardt, JD, Gallinghouse, GJ, Sanchez, JE, Horton, RP, Di Biase, L & Natale, A 2022, 'Prevalence, Management, and Outcome of Atrial Fibrillation and Other Supraventricular Arrhythmias in COVID-19 Patients', Cardiac electrophysiology clinics, vol. 14, no. 1, pp. 1-9. https://doi.org/10.1016/j.ccep.2021.10.001

TY - JOUR

T1 - Prevalence, Management, and Outcome of Atrial Fibrillation and Other Supraventricular Arrhythmias in COVID-19 Patients

AU - Magnocavallo, Michele

AU - Vetta, Giampaolo

AU - Della Rocca, Domenico G

AU - Gianni, Carola

AU - Mohanty, Sanghamitra

AU - Bassiouny, Mohamed

AU - Di Lullo, Luca

AU - Del Prete, Armando

AU - Cirone, Donatello

AU - Lavalle, Carlo

AU - Chimenti, Cristina

AU - Al-Ahmad, Amin

AU - Burkhardt, J David

AU - Gallinghouse, G Joseph

AU - Sanchez, Javier E

AU - Horton, Rodney P

AU - Di Biase, Luigi

AU - Natale, Andrea

PY - 2022/3

Y1 - 2022/3

N2 - COVID-19 mainly affects the respiratory system but has been correlated with cardiovascular manifestations such as myocarditis, heart failure, acute coronary syndromes, and arrhythmias. Cardiac arrhythmias are the second most frequent complication affecting about 30% of patients. Several mechanisms may lead to an increased risk of cardiac arrhythmias during COVID-19 infection, ranging from direct myocardial damage to extracardiac involvement. The aim of this review is to describe the role of COVID-19 in the pathogenesis of cardiac arrhythmias and provide a comprehensive guidance for their monitoring and management.

AB - COVID-19 mainly affects the respiratory system but has been correlated with cardiovascular manifestations such as myocarditis, heart failure, acute coronary syndromes, and arrhythmias. Cardiac arrhythmias are the second most frequent complication affecting about 30% of patients. Several mechanisms may lead to an increased risk of cardiac arrhythmias during COVID-19 infection, ranging from direct myocardial damage to extracardiac involvement. The aim of this review is to describe the role of COVID-19 in the pathogenesis of cardiac arrhythmias and provide a comprehensive guidance for their monitoring and management.

KW - Atrial Fibrillation/surgery

KW - Atrial Flutter

KW - COVID-19/complications

KW - Catheter Ablation/adverse effects

KW - Humans

KW - Prevalence

KW - SARS-CoV-2

KW - Tachycardia, Supraventricular

UR - http://www.scopus.com/inward/record.url?scp=85123385069&partnerID=8YFLogxK

U2 - 10.1016/j.ccep.2021.10.001

DO - 10.1016/j.ccep.2021.10.001

M3 - Article

C2 - 35221076

SN - 1877-9182

VL - 14

SP - 1

EP - 9

JO - Cardiac electrophysiology clinics

JF - Cardiac electrophysiology clinics

IS - 1

ER -

Prevalence, Management, and Outcome of Atrial Fibrillation and Other Supraventricular Arrhythmias in COVID-19 Patients

Abstract

Bibliographical note

Keywords

Access to Document

Handle.net

Other files and links

Fingerprint

Cite this